1. Home
  2. NKTR vs NUW Comparison

NKTR vs NUW Comparison

Compare NKTR & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • NUW
  • Stock Information
  • Founded
  • NKTR 1990
  • NUW 2008
  • Country
  • NKTR United States
  • NUW United States
  • Employees
  • NKTR N/A
  • NUW N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • NUW Investment Managers
  • Sector
  • NKTR Health Care
  • NUW Finance
  • Exchange
  • NKTR Nasdaq
  • NUW Nasdaq
  • Market Cap
  • NKTR 247.9M
  • NUW 246.1M
  • IPO Year
  • NKTR 1994
  • NUW N/A
  • Fundamental
  • Price
  • NKTR $0.93
  • NUW $13.37
  • Analyst Decision
  • NKTR Buy
  • NUW
  • Analyst Count
  • NKTR 3
  • NUW 0
  • Target Price
  • NKTR $4.00
  • NUW N/A
  • AVG Volume (30 Days)
  • NKTR 2.3M
  • NUW 45.3K
  • Earning Date
  • NKTR 11-07-2024
  • NUW 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • NUW 3.66%
  • EPS Growth
  • NKTR N/A
  • NUW N/A
  • EPS
  • NKTR N/A
  • NUW N/A
  • Revenue
  • NKTR $93,137,000.00
  • NUW N/A
  • Revenue This Year
  • NKTR $12.85
  • NUW N/A
  • Revenue Next Year
  • NKTR N/A
  • NUW N/A
  • P/E Ratio
  • NKTR N/A
  • NUW N/A
  • Revenue Growth
  • NKTR 5.53
  • NUW N/A
  • 52 Week Low
  • NKTR $0.47
  • NUW $12.45
  • 52 Week High
  • NKTR $1.93
  • NUW $14.44
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 33.04
  • NUW 31.60
  • Support Level
  • NKTR $0.89
  • NUW $13.40
  • Resistance Level
  • NKTR $1.04
  • NUW $13.99
  • Average True Range (ATR)
  • NKTR 0.07
  • NUW 0.11
  • MACD
  • NKTR -0.00
  • NUW -0.05
  • Stochastic Oscillator
  • NKTR 14.81
  • NUW 11.76

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About NUW Nuveen AMT-Free Municipal Value Fund

Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.

Share on Social Networks: